New patent expiration for Bausch And drug BESIVANCE
Annual Drug Patent Expirations for BESIVANCE Besivance is a drug marketed by Bausch And Lomb and is included in one […]
New patent expiration for Bausch And drug BESIVANCE Read Post »
Patent Expiration
New patent expiration for Heron Theraps drug SUSTOL
Annual Drug Patent Expirations for SUSTOL Sustol is a drug marketed by Heron Theraps Inc and is included in one
New patent expiration for Heron Theraps drug SUSTOL Read Post »
New patent expiration for Chiesi drug FERRIPROX
Annual Drug Patent Expirations for FERRIPROX Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It
New patent expiration for Palatin Technologies drug VYLEESI (AUTOINJECTOR)
Annual Drug Patent Expirations for VYLEESI+%28AUTOINJECTOR%29 Vyleesi (autoinjector) is a drug marketed by Palatin Technologies and is included in one
New patent expiration for Palatin Technologies drug VYLEESI (AUTOINJECTOR) Read Post »
Drug Patent Expirations for the Week of June 27, 2021
SEEBRI (glycopyrrolate) Novartis Patent: 9,962,338 Expiration: Jun 27, 2021 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of June 27, 2021 Read Post »
New patent expiration for Novartis drug UTIBRON
Annual Drug Patent Expirations for UTIBRON Utibron is a drug marketed by Novartis and is included in one NDA. There
New patent expiration for Sunovion Pharms drug APTIOM
Annual Drug Patent Expirations for APTIOM Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one
New patent expiration for Sunovion Pharms drug APTIOM Read Post »
Drug Patent Expirations for the Week of June 27, 2021
UTIBRON (glycopyrrolate; indacaterol maleate) Novartis Patent: 8,956,661 Expiration: Jun 27, 2021 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of June 27, 2021 Read Post »
New patent expiration for Novartis drug SEEBRI
Annual Drug Patent Expirations for SEEBRI Seebri is a drug marketed by Novartis and is included in one NDA. It
